Robert W. Adams

Diffusion Pharmaceuticals LLC develops and manufactures pharmaceutical products. The firm develops trans sodium crocetinate for use in cancers types in which tumor hypoxia (oxygen deprivation) is known to diminish the effectiveness of current treatments. The company was founded by Matthew W. Hantzmon, John L. Gainer, and David G. Kalergis in February 2001 and is headquartered in Charlottesville, VA.

International Trademark Association, Inc. operates association of brand owners and professionals to supporting trademarks and related intellectual property. It also operates through the offices located in Brussels, Santiago, Shanghai, Singapore and Washington and representatives in Geneva and New Delhi. The company was founded in 1878 and is headquartered in New York, NY.

The American Intellectual Property Law Association (AIPLA) is a professional organization that provides education, advocacy, and networking opportunities for intellectual property (IP) law practitioners. The organization is based in Arlington, VA and offers a variety of resources for its members, including access to committees focused on specific areas of IP law, continuing legal education (CLE) courses, and publications such as the quarterly journal and Innovate magazine. AIPLA also advocates for policies that support the protection of IP rights and provides resources for students and the public.

The Virginia State Bar provides access to various legal documents and forms for public use, including practice certificates, good standing certificates, and annual dues forms. The Virginia State Bar is based in Richmond, VA. The organization also offers resources related to disasters, COVID-19, and other legal matters. The Standing Committee on Legal Ethics answers ethics questions and issues opinions.

Nixon & Vanderhye P.C. engages in the provision of legal services. It offers patent prosecution and litigation, trademarks, post grant proceedings, internet protocol due diligence, and transactional practice, licensing, and copyrights services. The firm serves the biotechnology and life sciences, chemical and pharmaceutical, electronics, computer technology, communications and software, and the mechanical arts industries. The company was founded in 1985 and is headquartered in Arlington, VA.

RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL.

Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.